Correlation between prolidase activity and spatial memory functions in streptozotocin-induced diabetic rats by Prabha, Lakshmi & Subramanian, Sarada 
Indian Journal of Experimental Biology 
Vol. 59, February 2021, pp. 97-101 
Correlation between prolidase activity and spatial memory functions in 
streptozotocin-induced diabetic rats 
Lakshmi Prabha M & Sarada Subramanian* 
Department of Neurochemistry, National Institute of Mental Health and Neurosciences, Bengaluru-560 029, Karnataka, India 
Received 02 May 2020; revised 04 September 2020 
In the present study, we investigated the association of prolidase activity in streptozotocin (STZ) induced diabetic rat 
model with hippocampus-dependent spatial memory functions in chronic hyperglycemic conditions. Towards this, a single 
dose of STZ (30 mg/kg, i.p.) was administered to 4-month-old female Sprague Dawley rats and hyperglycemia was 
confirmed in all the STZ treated rats. To assess the spatial memory, at the time intervals of 9 days, 30 days and 90 days post 
STZ administration, the animals were subjected to Barnes maze task. Prolidase activity and glucose concentration in the 
serum were measured at these time points. With prolonged duration of hyperglycemia, severe impairment in spatial memory 
functions was seen in STZ induced diabetic rats which was correlatable with reduction in prolidase levels (P <0.05), thus 
suggesting that alterations in synaptic integrity due to prolidase mediated extracellular matrix remodeling as the possible 
mechanism of memory defects observed during chronic diabetes. 
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Diabetes mellitus, a metabolic disorder which causes 
impaired insulin signaling and glucose metabolism 
affects the synaptic plasticity in brain, particularly in 
hippocampus, leading to memory impairments1. 
Chronic hyperglycemia, through non-enzymatic 
glycation of extracellular matrix (ECM) proteins, 
structurally impairs the attachment of neurons to 
ECM2 and functionally alters the synaptic plasticity3. 
Further, structural and biochemical alterations and 
rigidity in ECM have been linked to cognitive 
dysfunction in experimental mouse models4. Matrix 
metalloproteases (MMPs), the proteolytic enzymes 
responsible for ECM remodeling and repair are 
modulated under such pathological conditions. The 
peptides generated by actions of MMPs, especially 
dipeptide containing C- terminal proline or hydroxy 
proline are further acted upon by yet another 
iminopeptidase, prolidase which is involved in ECM 
remodeling and spatial organization of molecules and 
cells5. Studies with dal mutant mice deficient for 
prolidase enzyme showed morphological defects in 
brain as evidenced by thinner collagen fibrils, loss of 
pial basement membrane integrity and disrupted 
cytoarchitecture as a result of altered ECM 
remodeling6,7.  
Prolidase is an important enzyme involved in the 
final step of degradation of collagen and recycling of 
proline. Another vital role of prolidase in CNS is the 
degradation of active neuropeptides, growth factors 
and cytokines that are rich in proline, and thus 
activation or inhibition of prolidase can cause 
significant physiological changes8. However, direct 
relation between diabetes and prolidase in 
hippocampus-dependent spatial memory has not been 
established yet. 
In the current study, streptozotocin (STZ) was used 
to induce diabetes in adult female Sprague-Dawley 
(SD) rats and considered as a suitable model for 
hippocampus-dependent spatial memory assessments 
owing to the fact that systemic perturbations in 
glucose level cause impaired insulin signaling and 
increased GSK3β activity resulting in exacerbated Aβ 
expression9 and tau hyperphosphorylation in the 
hippocampus, both of which lead to deficits in 
learning and memory10-12. With this background, an 
attempt has been made to elucidate the relationship of 
hippocampus-dependent spatial memory with 
prolidase, an MMP involved in ECM remodeling 
associated with neurodegeneration under chronic 
diabetic conditions. Towards this, serum prolidase 
activity was measured using gly-pro as the substrate. 
Spatial memory functions were assessed by Barnes 
maze task. The results suggest a positive correlation 
between prolidase activity and spatial memory.  
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Materials and Methods 
Animals 
Four-month-old Sprague Dawley female rats 
weighing 200-240 g procured from the Institute’s 
Central Animal Research Facility were housed in 
standard laboratory conditions. They were maintained 
under 12 h light/dark cycle and had free access to 
food and water ad libitum. All the experiments 
involved in the study were approved by the 




Streptozotocin, Gly-pro,porcine kidney prolidase, 
glucose assay kit,manganese chloride and Triton-X 
100 were purchased from Sigma-Aldrich, Bangalore. 
L-Proline, reduced L-glutathione, ninhydrin were 
purchased from Spectrochem Chemicals, Bangalore. 
All other chemicals and reagents used were of 
analytical grade and obtained locally. 
 
Experimental design 
The study consisted of four groups of rats (n=5 per 
group) as follows. Group I, Control, untreated rats; 
Group II-IV- Rats treated with STZ and memory 
recall in Barnes maze conducted for 9, 30 and 90 days 
post STZ administration, respectively. After the 
Barnes maze experiment, the blood samples were 
collected by cardiac puncture and the serum was 
separated by centrifugation at room temperature for 
15 min at 5000×g and stored in aliquots at −20°C 
until utilization for biochemical analysis (Fig. 1). 
 
Induction of diabetes  
A single dose of streptozotocin (30 mg/kg body wt.) 
dissolved in 250 µL of 0.1 M citrate buffer, pH 4.5 
was injected via i.p. route to experimental rats (Gr II-IV) 
and after three days of administration of STZ, for 
testing, blood samples were collected after overnight 
fasting and the blood glucose concentration was 
measured using glucose oxidase/peroxidase method 
using the commercially available kit (Sigma Aldrich, 
Bangalore). It was confirmed that all the STZ treated 
animals attained diabetic state after 72 h of STZ 
injection and remained hyperglycemic till the 
experimental end point. 
 
Barnes maze test 
The animals were subjected to behavioral test using 
Barnes maze task at definite time intervals of 9, 30 
and 90 days post STZ administration to evaluate the 
spatial learning and memory13. The maze consisted of 
an open circular brightly lit platform with 12 holes 
with only one hole leading to a dark escape box. The 
positioning of the box remained constant throughout 
the entire task. The behavioural test consisted of two 
habituation trials on the first day and nine acquisition 
trials (three trials/day) over a period of next three 
days. After a gap of four days, retention of memory 
was evaluated by three trials (one day). The platform 
and escape box were cleaned after every trial with 
70% ethanol. The number of incorrect holes explored 
(nose pokes in each hole), counted as errors, and the 
time taken (latency) to find the escape box by each 
group during the acquisition phase and the day of 
memory retention was recorded and compared with 
the performance of control. 
 
Prolidase activity assay 
Prolidase activity in serum was determined using 
colorimetric method as described by Myara et al.14 and 
 
 
Fig. 1 — Experimental design. The nomenclature of the experimental groups of rats, time lines of administration of streptozotocin (STZ);
habituation, training and recall phases of Barnes maze task; and blood sample collection for estimation of glucose levels and prolidase 
activity in the serum. (n=5 in each group)  




the proline levels liberated enzymatically from an 
exogenous glycyl-L-proline (Gly-Pro) substrate was 
quantitated using Chinard’s reagent15. Briefly, 10 µL 
of serum sample was added to 500 µL of assay buffer 
[50 mM Tris–HCl, pH 8.0, containing 40 mM MnCl₂ 
and 0.4 mM GSH] followed by incubation for 30 min 
at 40°C to activate the enzyme. Subsequently, 500 µL 
of substrate mix containing 40 mM Gly-Pro in 50 mM 
Tris–HCl, pH 8.0 and 15 mM MnCl₂ was added to the 
preincubated serum and the reaction continued at 
40°C for 15 min. The activity measured with 1 U of 
commercially available porcine kidney prolidase 
served as reference. The reaction was then stopped by 
adding 50 µL of 0.45 M trichloroacetic acid. The 
samples were then centrifuged for 15 min at 5,000×g, 
and 0.25 mL of supernatant was used for proline 
estimation. For this, to 0.25 mL of the supernatant, 
0.5 mL of Chinard’s reagent (2.5% ninhydrin 
dissolved by heating at 70oC in a mix of 60 parts of 
glacial acetic acid and 40 parts of orthophosphoric 
acid) and 0.5 mL of glacial acetic acid were added 
and the mixture was incubated for 10min at 90°C. The 
amount of proline released was determined by 
measuring the absorbance at 515 nm using UV-Vis 




All data analysis was carried out using Graph pad 
prism software (version 8.0.1). Data are presented as 
mean ± S.E.M. P value less than 0.05 was considered 
statistically significant. Barnes maze data for learning 
was analyzed using two-way ANOVA. Student’s 
unpaired 𝑡-test was used to compare each group with 
control, and the correlation between the parameters 
were analyzed by Pearson’s correlation.  
 
Results 
In this study, the average initial weight of rats was 
220 ± 21 g. At the end of experiments, the control 
group gained weight with progression of time (279 ± 
25 g) whereas the STZ treated diabetes group weighed 
lesser (246 ± 19 g) to that of the control group. It was 
confirmed that all the STZ treated rats which had 
attained diabetic state after 72 h of injection (glucose 
concentration > 100 mg/dL) remained hyperglycemic 
till the experimental end point (Fig. 2A). 
Both the control and STZ-treated rats with acute to 
chronic diabetes was evaluated by the Barnes maze test 
for hippocampus dependent spatial memory acquisition 
and retention at various time points. The aversion 
towards bright light motivates the animals to seek the 
dark escape hole hidden beneath the maze platform. 
Neither of the animal groups showed any significant 
difference in the latency or errors made during the 
learning phase. However, during memory recall, all the 
experimental groups made a greater number of errors 
in locating the escape hole when compared to controls, 
with Gr III (30 days) and Gr. IV (90 days) showing 
many more errors which were statistically significant 
indicating impairment in spatial memory (Fig. 2B) with 
chronicity of hyperglycemic state. The activity levels 
of prolidase enzyme in the serum samples gradually 
decreased with chronicity of diabetes in STZ treated 
rats when compared with control. Even though the 
prolidase activity in rats was reduced in Group II rats 
 
 
Fig. 2 — Biochemical analyses and behavioural assessments of control and STZ treated rats. (A) Fasting blood glucose levels were
significantly elevated in upon STZ treatment over the control animals. P <0.01 (**); (B) During memory recall in Barnes maze task, >30 
days post STZ Groups of rats committed greater number of errorsin comparison to the untreated control rats. P <0 .05 (*), P<0.001 (#); 
and(C) Serum prolidase activity gradually decreased with increase in the duration of hyperglycemic state in STZ treated rats. P <0 .05 (*), 
P <0.0744 (#) 




(9 days post STZ injection), it was statistically not 
significant. A trend in the statistically significant 
difference in prolidase activity between control and 
Group III (30 days post STZ) (p=0.0744) was noted. 
More importantly, in Group IV rats (90 days post STZ 
administration), a significant reduction in prolidase 
activity was observed (Fig. 2C). With increased 
glucose concentration in post STZ treated groups, a 
concomitant decrease in prolidase activity was 
observed suggesting a negative correlation between 
these parameters (Fig. 3A). With respect to memory 
function, it was observed that prolidase activity 
reduced with increase in the number of errors made in 
Barnes maze by the STZ treated rats. This indicates  
a negative correlation of prolidase with memory 
deficits and/or positive correlation with memory 
function (Fig. 3B). 
Discussion 
Clinical and epidemiological studies have confirmed 
that impaired metabolic parameter associated with 
diabetes like hyperglycemia, perturbed function of 
insulin, and IGF-1 signalling correlated positively with 
development of cognitive deficits16,17. Intraperitoneal 
STZ injection impairs brain insulin signalling pathway 
and GSK 3β activation in hippocampus by decreasing 
the inhibitory phosphorylation at serine 9 site18. 
Increased GSK 3β activity results in increase in tau 
phosphorylation and accumulation in hippocampus 
contributing to neuronal dysfunction and cognitive 
impairment19. During the state of hyperglycemia, 
reduction in protein synthesis such as SNAP-2520 
coupled with glycation of ECM proteins such as 
collagen and the concentration of selective adenosine 
receptors (A2ARs) in the hippocampus
21 may play a 
prominent role in controlling the synaptic damage22,23.  
In the present study, poor performance in Branes 
maze exhibited by the STZ- treated rats is attributed to 
decreased synaptic strength as a result of aberrant ECM 
modification due to reduced prolidase activity under 
chronic hyperglycemic conditions. Additional functions 
of prolidase including degradation of endogenous 
dipeptides for proline regeneration and recycling may 
also be affected during chronic diabetes. It has recently 
been reported that decreased prolidase activity impairs 
the effective recycling of proline containing dipeptides 
and indirectly results in accumulation of proline-rich 
proteins24. This results in accumulation of these 
dipeptides as aggregosomes, suggested to interfere with 
synaptic connectivity. Subsequently, these proline-rich 
proteins induce apoptotic signal and neuronal cell loss. 
On similar lines, in the present study, the compromise in 
spatial memory in STZ induced diabetic rats could be 
due to alterations in ECM modulating enzymes, in 
particular, the prolidase activity. The reduction in 
prolidase activity observed in the present study is 
supported by the evidence available in the literature 
regarding diabetes induced impairment in IGF-1 
signaling with lowered nitric oxide levels as the 
subsequent downstream events25. A recent study has 
further suggested that diabetes induces reduction in IGF-
1 level in STZ treated rats26. It is pertinent to mention at 
this juncture that prolidase is primarily regulated by 
IGF-1 and NO levels27,28.  
 
Conclusion 
In the present study, the results of prolidase activity 
strongly correlated inversely with glucose levels in 
diabetic rats. More importantly, the enzyme activity 
 
 
Fig. 3 — Correlation of prolidase activity with serum glucose
levels and memory deficits in Barnes maze task. (A) Prolidase
activity was negatively correlated with glucose concentration
when analysed using Pearson’s correlation coefficient.(r=-0.6778,
**P <0.01); and (B) Prolidase activity was negatively correlated
with memory deficits when analysed using Pearson’s correlation
coefficient (r=-0.5995, *P <0.05) 
 




negatively correlated with memory deficits and 
positively correlated with memory functions in the 
present study. These results imply that, in principle, 
prolidase activity can serve as an indicator of spatial 
memory deficits often noted in chronic diabetes. 
However, further studies are warranted to elucidate the 
mechanism of prolidase mediated progression/ recovery 
from memory deficits associated with diabetes. 
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